找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hypertension and Hormone Mechanisms; Robert M. Carey (David A. Harrison III Distinguish Book 2007 Humana Press 2007 Angiotensin II.aldoste

[復制鏈接]
樓主: 監(jiān)督
21#
發(fā)表于 2025-3-25 06:16:13 | 只看該作者
22#
發(fā)表于 2025-3-25 09:37:49 | 只看該作者
23#
發(fā)表于 2025-3-25 12:09:44 | 只看該作者
24#
發(fā)表于 2025-3-25 19:37:11 | 只看該作者
oupling. By its emphasis on biophysical aspects of a prevalent clinical condition, the monograph is unique in its perspective and focus. The breadth of information in the chapters all in one place will be of value to clinicians and researchers at all levels. Modern research approaches and clinical u
25#
發(fā)表于 2025-3-25 20:26:40 | 只看該作者
Ernesto L. Schiffrin MD, PhD, FRCPCoupling. By its emphasis on biophysical aspects of a prevalent clinical condition, the monograph is unique in its perspective and focus. The breadth of information in the chapters all in one place will be of value to clinicians and researchers at all levels. Modern research approaches and clinical u
26#
發(fā)表于 2025-3-26 03:53:15 | 只看該作者
Cardiac and Vascular Renin-Angiotensin Systemsype 1 plasma membrane (AT.) receptor. The AT1 is a seven-transmembrane spanning, heterotrimeric G protein-coupled receptor (GPCR) that activates multiple signal transduction pathways. An AT. receptor, which in large part couples to effector pathways that antagonize the AT. effects, is also present i
27#
發(fā)表于 2025-3-26 07:10:27 | 只看該作者
Insulin Resistance and Hypertensione blood pressure, the greater the chance of myocardial infarction, heart failure, stroke, and renal disease. The CVD risk escalates further when other risk factors are present, as in patients with metabolic syndrome.
28#
發(fā)表于 2025-3-26 08:58:50 | 只看該作者
Book 2007ted areas of diagnosis and therapy...With a focus on new developments in hormones and autacoids related to hypertension, Hypertension and Hormone Mechanisms provides a resource that will lead to new, active research in the fundamental mechanisms of hypertension..
29#
發(fā)表于 2025-3-26 14:44:48 | 只看該作者
Angiotensin IV Binding Site.). This binding site was termed as the angiotensin AT. receptor by an IUPHAR nomenclature committee (.). This AT. receptor site is pharmacologically distinct from both Ang II AT. and AT. receptors, and bound Ang II at only micromolar affinity.
30#
發(fā)表于 2025-3-26 18:55:24 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 15:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
雅江县| 尼玛县| 灵川县| 浪卡子县| 广平县| 阆中市| 云南省| 鲜城| 萝北县| 通河县| 柳河县| 弋阳县| 滦南县| 清新县| 津南区| 淮阳县| 三都| 光泽县| 灵寿县| 宜城市| 吉水县| 潼关县| 将乐县| 韩城市| 敦煌市| 江源县| 克东县| 舒兰市| 西和县| 崇义县| 绍兴市| 米泉市| 开江县| 枣庄市| 林西县| 大安市| 西青区| 通许县| 汨罗市| 宁南县| 册亨县|